Loading…

Carcinoma of the male breast

Male breast cancer accounts for less than 1% of all breast cancers in the United States. The low incidence of this disease prevents therapeutic questions from being addressed in prospective randomized trials. As such, treatment algorithms have generally been extrapolated from those used in female br...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in oncology 2000-08, Vol.1 (3), p.221-227
Main Authors: De los Santos, J F, Buchholz, T A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Male breast cancer accounts for less than 1% of all breast cancers in the United States. The low incidence of this disease prevents therapeutic questions from being addressed in prospective randomized trials. As such, treatment algorithms have generally been extrapolated from those used in female breast cancer. Similar to female breast cancer, lymph node involvement and the size of the primary tumor are the most important factors in predicting disease-free and overall survival. Modified radical mastectomy remains the standard local therapeutic approach, with radiation therapy indicated for patients who have clinicopathologic features associated with a high risk for postmastectomy chest wall or lymph node recurrence. Similar to female breast cancer, adjuvant chemotherapy or hormonal therapy is indicated in the majority of men with breast cancer, specifically those with tumors larger than 1 cm or those with lymph node-positive disease.
ISSN:1527-2729
1534-6277
1534-5277
DOI:10.1007/s11864-000-0033-x